Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Sensors (Basel) ; 21(1)2021 Jan 01.
Article in English | MEDLINE | ID: mdl-33401414

ABSTRACT

During hundreds of millions of years of evolution, insects have evolved some of the most efficient and robust sensing organs, often far more sensitive than their man-made equivalents. In this study, we demonstrate a hybrid bio-technological approach, integrating a locust tympanic ear with a robotic platform. Using an Ear-on-a-Chip method, we manage to create a long-lasting miniature sensory device that operates as part of a bio-hybrid robot. The neural signals recorded from the ear in response to sound pulses, are processed and used to control the robot's motion. This work is a proof of concept, demonstrating the use of biological ears for robotic sensing and control.


Subject(s)
Grasshoppers , Robotics , Animals , Ear, Middle , Lab-On-A-Chip Devices , Sound
2.
Front Cell Neurosci ; 13: 346, 2019.
Article in English | MEDLINE | ID: mdl-31474832

ABSTRACT

Mutations in superoxide dismutase (SOD1) are the second most common cause of familial amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease caused by the death of motor neurons in the brain and spinal cord. SOD1 neurotoxicity has been attributed to aberrant accumulation of misfolded SOD1, which in its soluble form binds to intracellular organelles, such as mitochondria and ER, disrupting their functions. Here, we demonstrate that mutant SOD1 binds specifically to the N-terminal domain of the voltage-dependent anion channel (VDAC1), an outer mitochondrial membrane protein controlling cell energy, metabolic and survival pathways. Mutant SOD1G93A and SOD1G85R, but not wild type SOD1, directly interact with VDAC1 and reduce its channel conductance. No such interaction with N-terminal-truncated VDAC1 occurs. Moreover, a VDAC1-derived N-terminal peptide inhibited mutant SOD1-induced toxicity. Incubation of motor neuron-like NSC-34 cells expressing mutant SOD1 or mouse embryonic stem cell-derived motor neurons with different VDAC1 N-terminal peptides resulted in enhanced cell survival. Taken together, our results establish a direct link between mutant SOD1 toxicity and the VDAC1 N-terminal domain and suggest that VDAC1 N-terminal peptides targeting mutant SOD1 provide potential new therapeutic strategies for ALS.

3.
Cell Death Dis ; 9(2): 107, 2018 01 25.
Article in English | MEDLINE | ID: mdl-29371591

ABSTRACT

Mutations in superoxide dismutase (SOD1) cause amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease caused by the progressive loss of motor neurons in the brain and spinal cord. It has been suggested that toxicity of mutant SOD1 results from its misfolding, however, it is yet unclear why misfolded SOD1 accumulates specifically within motor neurons. We recently demonstrated that macrophage migration inhibitory factor (MIF)-a multifunctional protein with cytokine/chemokine activity and cytosolic chaperone-like properties-inhibits the accumulation of misfolded SOD1. Here, we show that MIF inhibits mutant SOD1 nuclear clearance when overexpressed in motor neuron-like NSC-34 cells. In addition, MIF alters the typical SOD1 amyloid aggregation pathway in vitro, and, instead, promotes the formation of disordered aggregates, as measured by Thioflavin T (ThT) assay and transmission electron microscopy (TEM) imaging. Moreover, we report that MIF reduces the toxicity of misfolded SOD1 by directly interacting with it, and that the chaperone function and protective effect of MIF in neuronal cultures do not require its intrinsic catalytic activities. Importantly, we report that the locked-trimeric MIFN110C mutant, which exhibits strongly impaired CD74-mediated cytokine functions, has strong chaperone activity, dissociating, for the first time, these two cellular functions. Altogether, our study implicates MIF as a potential therapeutic candidate in the treatment of ALS.


Subject(s)
Amyloid/chemistry , Amyotrophic Lateral Sclerosis/pathology , Macrophage Migration-Inhibitory Factors/pharmacology , Protein Aggregates/drug effects , Protein Folding , Superoxide Dismutase-1/chemistry , Superoxide Dismutase-1/toxicity , Active Transport, Cell Nucleus/drug effects , Amyotrophic Lateral Sclerosis/metabolism , Biocatalysis , Cell Line , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Humans , Models, Biological , Mutant Proteins/metabolism , Mutant Proteins/toxicity , Protein Binding/drug effects , Protein Folding/drug effects , Protein Multimerization/drug effects , Recombinant Proteins/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...